Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Novartis Group Companies
Dec 01, 2018
Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program
Oct 02, 2018
Alcon introduces enhanced WaveLight® Refractive Suite to optimize the patient and surgeon LASIK experience
Aug 02, 2018
Novartis announces US renewables agreement to reduce greenhouse gas emissions
Jul 20, 2018
Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION(TM) to simplify, customize vitreoretinal surgery
Jul 18, 2018
Novartis Kisqali® now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
Jul 12, 2018
Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community
Jul 06, 2018
Sandoz Inc. and its affiliate, Novartis Pharmaceuticals Corporation, voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance
Jun 27, 2018
Novartis announces funding for patient advocacy initiatives to support and empower metastatic breast cancer community
Jun 19, 2018
Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis
Jun 16, 2018
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Jun 15, 2018
Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
Jun 03, 2018
Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
Jun 02, 2018
New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy
May 30, 2018
FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
May 17, 2018
Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
May 11, 2018
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
May 01, 2018
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Apr 30, 2018
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Apr 25, 2018
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Apr 10, 2018
Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures
Page 1
››
Latest News
Apr 25, 2024
Oceaneering Reports First Quarter 2024 Results
Apr 25, 2024
NewMarket Corporation Reports First Quarter 2024 Results
Apr 25, 2024
Orion S.A. Earns Platinum Sustainability Rating by EcoVadis
Apr 25, 2024
Virginia American Water Finalizes Acquisition of Town of Cape Charles Water and Wastewater Systems
Apr 25, 2024
Ecolab to Webcast Annual Meeting on May 2, 2024
Apr 25, 2024
RYAM Schedules First Quarter Earnings Release
Apr 25, 2024
ProPetro Increases Share Repurchase Authorization to $200 million
Apr 25, 2024
Spruce Power CEO Chris Hayes to Participate in a Water Tower Research Fireside Chat on Friday, April 26 at 11...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events